This is the sixth chapter of seven of the series. We hope to wrap this up in seven chapters, and not go to an eighth. What was not mentioned in the last chapter, is that in the first Temple period (1011 BC to 587 BC), the High Priest sprinkled blood on the Arc in […]
ICIMOD: ‘A Global Platform For Adapting To Climate Change’
ICIMOD, reaching out people to adapt to climate change: internationally climate change is now a biggest concern. Probably every corner of the nature is showing heavy impact due to the frequent changes year after year. The ecosystem of our hills is getting out of balance due to climate change. Therefore, with world class experts and […]
SAARC and shark: need to de-feudalize democracy
The 18th South Asian Association for Regional Cooperation (SAARC) summit has concluded Thursday with a 36-point Kathmandu Declaration. The two-day summit held in Kathmandu from 26-27 November mainly emphasized on the regional cooperation for security and anti-terrorism network, mutual trade and energy cooperation. The Indian Prime Minister Narendra Modi and the Pakistani Prime Minister Nawaj […]
The Truth of Genesis: An Open Letter to the Archbishop of Westminster
Earlier (November 2014), I wrote the article “The Truth of Genesis: The Papacy Refuses To Teach the Truth of Genesis”. It was in response to the ungodly remarks of Pope Francis, a Jesuit, who displayed his ignorance and/or disdain of the scriptures by saying that “God is not a magician”, and “Evolution is not inconsistent […]
INDO-PAK DIALOGUE AND THE KASHMIR ISSUE
New Delhi and Islamabad may be holding diametrically opposite and conflicting views on Kashmir. However, after seeing their slumbering pace and perfunctory attempts to resolve this long outstanding issue, it seems that they both share the common belief that this is not a matter of great urgency. So, on those rare occasions when the Kashmir […]
Investor Alert: Impax Laboratories Inc (NASDAQ:IPXL) under Investigation over potential Wrongdoing
The Shareholders Foundation announces that an investigation on behalf of current long-term investors in shares of Impax Laboratories Inc (NASDAQ:IPXL) is ongoing concerning potential breaches of fiduciary duties by certain directors and officers of Impax Laboratories. Investors who are current long term investors in Impax Laboratories Inc (NASDAQ:IPXL) shares, have certain options and should contact […]
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 50
- Next Page »